HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY:

# Drug Count
0 CYCLOPHOSPHAMIDE 4
1 CYCLOPHOSPHAMIDE FOR INJECTION 4
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 4
3 ETOPOSIDE 4
4 GEMCITABINE HYDROCHLORIDE 4
5 GLOFITAMAB 4
6 OXALIPLATIN 4
7 PREDNISONE 4
8 RITUXIMAB 4
9 DOXORUBICIN 3
See all common drugs associated with HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY

HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLOFITAMAB 4 0.0015
1 GEMCITABINE HYDROCHLORIDE 4 0.0001
2 DOXORUBICIN HYDROCHLORIDE 2 0.0001
3 ETOPOSIDE 4 0.0001
4 OXALIPLATIN 4 0.0001
5 DOXORUBICIN 3 0.0000
6 CYCLOPHOSPHAMIDE FOR INJECTION 4 0.0000
7 CYCLOPHOSPHAMIDE 4 0.0000
8 RITUXIMAB 4 0.0000
9 PREDNISONE 4 0.0000
See all drugs enriched for association with HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY

HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 4 0.0010
1 Topoisomerase Inhibitor [EPC] 4 0.0001
2 Alkylating Drug [EPC] 4 0.0000
3 Platinum-based Drug [EPC] 4 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
5 Corticosteroid [EPC] 4 0.0000
6 Thalidomide Analog [EPC] 1 0.0000
See all drug classes enriched for association with HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY